3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
14
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, Follicular
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma
5
Sarcoma, Ewing
3
Rhabdomyosarcoma, Embryonal
3
Rhabdomyosarcoma
3
Neoplasms
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Down Syndrome
3
Rhabdomyosarcoma, Alveolar
2
Medulloblastoma
2
Lymphoproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell, Marginal Zone
2
Hepatoblastoma
2
Wilms Tumor
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Sarcoma
1
Rhabdoid Tumor
1
Pleuropulmonary blastoma
1
PRETEXT I Hepatoblastoma
1
Osteosarcoma
1
Neuroblastoma
1
Interventions
Cyclophosphamide
9
fludarabine
7
Dexamethasone
7
pomalidomide
6
Rituximab
6
pembrolizumab
5
selinexor
4
obinutuzumab
4
glofitamab
4
Lenalidomide
4
daratumumab
3
belantamab mafodotin
3
Temozolomide
3
Gemcitabine
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
fludarabine phosphate
2
enzalutamide
2
cemiplimab
2
carfilzomib
2
abemaciclib
2
PF06821497
2
Mesna
2
Lisaftoclax
2
Injections
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Vincristine
×
30 days
×
Clear all
No trials found.